Nanobots Therapeutics is a deeptech company focused on developing and commercializing
MotionTx platform.
COMPANY
Nanobots Therapeutics is a deeptech company focused on developing and commercializing MotionTx platform.
MotionTx technology enables the development of unique therapeutic entities that penetrate tissues with superior efficacy, enhancing drug accumulation in target cells.
The company is a spin-off of ICREA and IBEC and is the result of the research led by Prof. Samuel Sánchez.
MotionTx technology enables the development of unique therapeutic entities that penetrate tissues with superior efficacy, enhancing drug accumulation in target cells.
The company is a spin-off of ICREA and IBEC and is the result of the research led by Prof. Samuel Sánchez.
OUR SCIENCE
Our science is pioneering the development of MotionTx platform, a new modality of therapeutic entities with unique properties to penetrate tissues and accumulate in target cells.
MOTION TX PLATFORM
New Modality
Novel class of drugs with unique tissue penetration capabilities
Platform Technology
Can carry a variety of drugs for different therapeutic indications
Targeted Delivery
Maximizing local routes of administration